TRIAD Appendicitis Decision-making Surveys

Launched by UNIVERSITY OF WASHINGTON · May 24, 2023

Keywords

ClinConnect Summary

The TRIAD Appendicitis Decision-making Surveys is a clinical trial aimed at understanding how patients decide between two treatment options for appendicitis: surgery (appendectomy) and antibiotics. For many years, surgery has been the standard treatment for appendicitis, but recent studies suggest that antibiotics might be a good alternative for some patients. This trial will gather feedback from participants about their satisfaction with their treatment decision and any regrets they might have. The goal is to create better support tools that help patients make informed choices that align with their personal preferences and values.

To join this trial, participants need to be adults who the medical team believes can consider either surgery or antibiotics for their appendicitis treatment. However, certain individuals cannot participate, including pregnant women, those with weakened immune systems, or anyone with serious complications related to their appendicitis. If eligible, participants will share their experiences and opinions, which will help shape future decision-making resources for patients facing similar health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any patient the clinical team feels is appropriate for considering either surgery or antibiotics for their initial appendicitis treatment
• Exclusion Criteria:
• • Pregnant patients
• • Immunocompromised patients
• • Patients with high complication risk of recurrent infections
• • Evidence of severe phlegmon or walled off abscess or free air on imaging
• • Septic shock
• • Diffuse peritonitis
• • Patients under 18 years old